Navigation Links
HCLA Commends President Bush's Strong and Continuing Commitment to Medical Liability Reform
Date:1/29/2008

Calls on Congress to End Lawsuit Abuse as a critical Part of Health Care Reform

WASHINGTON, Jan. 29 /PRNewswire-USNewswire/ -- The Health Coalition on Liability and Access (HCLA) commends President Bush's stalwart support of medical liability reform and his call on the U.S. Congress in last night's State of the Union message to end the epidemic of medical lawsuit abuse that is threatening patient access to medical care. Standing before the Congress, the President forthrightly called on that body to "confront the epidemic of junk lawsuits" as an essential step to ensuring that important "decisions about your medical care are made in the privacy of your doctor's office."

"President Bush has been a strong supporter of medical liability reform throughout his Presidency," said Shawn Martin, HCLA's Chair, "and he made sure in his last State of the Union message to remind Congress that ending the plague of lawsuit abuse must be an essential part of any future health care reform package they may consider. President Bush understands that patients pay the price for our out-of-control medical liability system and that meritless lawsuits are causing critical shortfalls in health care in states across the nation."

In many states, lawsuit abuse has driven insurance premiums so high that doctors can no longer afford them, forcing many to leave practice or cut back on life-saving procedures that carry a high risk. The American people understand the danger and have consistently voiced support of comprehensive medical liability reform in national polls. The latest polls show that three quarters (74%) of Americans believe that their access to quality medical care is threatened because our broken medical liability system is forcing good doctors out of medicine; and a similar number (75% to 76%) want their elected representatives to pass medical liability reform with reasonable limits on non-economic damages.

"Medical liability reform must be a
'/>"/>

SOURCE Health Coalition on Liability and Access
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
2. AHIP Commends IOM for Recommending Comparative Effectiveness Program
3. Leading National Patient Advocacy Group Commends Insurance Industrys Recognition, Focus on Growing National Problem of Uninsured and Underinsured Americans
4. AMA Commends Independent Health for Joining Industry Shift on Physician Performance Measurement
5. FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
6. Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius Opposition Slate
7. NCOA Commends Long Term Care Commission Report
8. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
9. AMA Commends Aetna for Quality First Commitment
10. National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning
11. CHPA Commends Senator Biden on Legislation Aimed at Curbing Medicine-Abuse Trend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 As AndroGel lawsuits and testosterone ... E. Johnson, Jr. has been appointed as co-lead counsel ... testosterone medications. Since the Fall of 2013, Ron and ... diligently to investigate and prosecute the claims of men ... clots as a result of taking testosterone. As a ...
(Date:8/1/2014)... 01, 2014 Growing prevalence of ... healthcare reforms are boosting healthcare market growth, although ... discounts and increasing generic consumption is a major ... million in 2013, having grown at a Compound ... The implementation of the Health Transformation Program (Saglikta ...
(Date:8/1/2014)... August 01, 2014 The "Antimicrobial ... such as Zinc Oxide, Titanium Dioxide, and Zinc ... & Construction, Food & Beverages, Textiles, and others), ... - Global Trends and Forecasts to 2018" analyzes ... drivers, opportunities, and trends in the diverse geographical ...
(Date:8/1/2014)... According to new market research ... North America, Europe, & ROW), by Vehicle Type ... (Gasoline & Diesel), by After-Treatment Device (DPF, DOC, ... Forecasts to 2019", defines and segments the global ... major countries in all the regions, and estimates ...
(Date:8/1/2014)... The Cardiovascular Research Foundation (CRF) has announced ... will be presented at next month,s Transcatheter Cardiovascular ... premier educational meeting specializing in interventional cardiovascular medicine, ... at the Walter E. Washington Convention Center in ... TCT often direct the course of patient therapies. ...
Breaking Medicine News(10 mins):Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4
... doctor Kunal Saha, fighting a case of medical negligence ... writ petition before the Calcutta High Court seeking action ... functionaries for their 'deliberate violation' of the Right to ... on Jan 11 also named WBMC president Ashok Chowdhury, ...
... invasive heart-muscle biopsies that check for organ rejection are ... simple blood test that analyzes a patient’s genes has ... it can accurately detect the absence of heart transplant ... editorial authored by a consensus team of international heart ...
... MRI in surgical decision-making minimizes the potential for unsuccessful ... to predict surgical// outcomes. A Tesla is a unit ... strongest commercially available. ,In their report, Mayo ... team used an advanced magnetic resonance imaging (MRI) system ...
... established the prevailing trend among kids of today, who ... fix snack options.// ,Researchers from university of ... unwholesome truth about eating wrong from a tender age. ... unhealthy eating, which is a leading cause of increasing ...
... Rockville-The Food and Drug Administration has given the go-ahead ... facial lipoatrophy, otherwise called fat loss,// occurring in patients ... found to assist in the manufacture of collagen. ... FDA embarked on a study of 100 HIV patients ...
... more guns, more murders. ,In a statement bound ... Health came out with results of a survey, published in ... topic in US, where the case for it, is still ... a gun,according to current data. ,Researchers analyzed ...
Cached Medicine News:Health News:Indian American Doctor Fights for Information 2Health News:Accuracy of Gene Expression Test for Heart Transplant Patients Confirmed 2Health News:A New Technology for Safe Tumor Surgery 2
(Date:7/31/2014)... SAN DIEGO, July 31, 2014  ResMed Inc. (NYSE: ... and for the fiscal year ended June 30, 2014.  Revenue ... quarter ended June 30, 2013 (a 1 percent decrease on ... increase of 20 percent compared to the quarter ended June ... $0.61, an increase of 22 percent compared to the quarter ...
(Date:7/31/2014)... SAN FRANCISCO, July 31, 2014 Nektar Therapeutics (Nasdaq: ... the second quarter ended June 30, 2014. ... were $301.4 million as compared to $309.1 million at March ... time for Nektar as we look forward to significant milestones ... W. Robin, President and Chief Executive Officer of Nektar. "The ...
(Date:7/31/2014)... 31, 2014  Decision Resources Group,s experts ... by the Affordable Care Act (ACA), which ... pharmaceutical therapies. The ACA altered how Managed ... regulations and expanded access via government-supported programs. ... exchanges—state-based marketplaces set up by states or ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4
... Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and ... (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee ... 01 Blood Glucose Meters as the first and second ... of service as noted by the Uniform Formulary Beneficiary ...
... Oct. 28, 2011 Pearl Therapeutics Inc. presented ... foundations of the Company,s cosuspension technology which uses ... via pressurized metered dose inhalers (MDIs). Two posters ... Association of Pharmaceutical Scientists annual meeting in Washington ...
Cached Medicine Technology:ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary. 2Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform 2Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: